Kalehua Capital Management as of March 31, 2026
Portfolio Holdings for Kalehua Capital Management
Kalehua Capital Management holds 25 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX) | 18.0 | $25M | 218k | 116.29 | |
| X4 Pharmaceuticals Com New (XFOR) | 10.9 | $15M | 3.7M | 4.13 | |
| Surrozen Com New (SRZN) | 7.9 | $11M | 385k | 29.13 | |
| Veradermics Common Stock | 6.5 | $9.2M | 146k | 63.15 | |
| Relay Therapeutics (RLAY) | 6.3 | $9.0M | 902k | 9.95 | |
| Sionna Therapeutics (SION) | 5.6 | $7.9M | 197k | 40.09 | |
| Aclaris Therapeutics (ACRS) | 4.9 | $6.9M | 1.8M | 3.75 | |
| Inhibikase Therapeutics Com New (IKT) | 4.5 | $6.4M | 3.8M | 1.68 | |
| Oruka Therapeutics (ORKA) | 4.1 | $5.8M | 119k | 49.05 | |
| Pharvaris N V (PHVS) | 4.0 | $5.6M | 199k | 28.25 | |
| Uniqure NV SHS (QURE) | 3.4 | $4.8M | 291k | 16.35 | |
| Septerna (SEPN) | 3.3 | $4.7M | 195k | 24.03 | |
| Compass Pathways Sponsored Ads (CMPS) | 3.2 | $4.5M | 820k | 5.53 | |
| Athira Pharma (LONA) | 2.9 | $4.0M | 394k | 10.28 | |
| Damora Therapeutics Com New (DMRA) | 2.5 | $3.6M | 139k | 25.90 | |
| Gossamer Bio (GOSS) | 2.4 | $3.4M | 10M | 0.33 | |
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 2.3 | $3.3M | 176k | 18.64 | |
| Tyra Biosciences (TYRA) | 2.0 | $2.9M | 75k | 38.30 | |
| Pepgen (PEPG) | 1.3 | $1.8M | 1.0M | 1.77 | |
| Instil Bio Com New (TIL) | 1.1 | $1.5M | 183k | 8.24 | |
| Tenaya Therapeutics (TNYA) | 1.0 | $1.4M | 2.0M | 0.69 | |
| Korro Bio (KRRO) | 0.9 | $1.2M | 109k | 11.32 | |
| Kalaris Therapeutics (KLRS) | 0.6 | $782k | 136k | 5.77 | |
| DiaMedica Therapeutics Com New (DMAC) | 0.3 | $423k | 63k | 6.77 | |
| Loop Inds (LOOP) | 0.3 | $361k | 348k | 1.04 |
